Synairgen plc (LON:SNG – Get Rating)'s stock price crossed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of GBX 12.55 ($0.15) and traded as low as GBX 9 ($0.11). Synairgen shares last traded at GBX 9 ($0.11), with a volume of 897,679 shares changing hands.
Synairgen Stock Down 6.5 %
The company has a fifty day simple moving average of GBX 12.55 and a 200-day simple moving average of GBX 16.22. The company has a quick ratio of 6.35, a current ratio of 6.35 and a debt-to-equity ratio of 0.09. The firm has a market cap of £18.12 million, a P/E ratio of -69.23 and a beta of -2.20.
Synairgen Company Profile
(Get Rating)
Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease; and LOXL2 inhibitor for the treatment of idiopathic pulmonary fibrosis (IPF) disease.
See Also
- First Republic Bank Hits New Low, Dimon Pushes for More Cash
- Mullen Automotive: Investment? No. Compelling Speculation, Yes
- GBTC: The One Place to Buy Bitcoin for 58 Cents on the Dollar
- General Mills Retreats To Buy Zone Ahead Of Earnings
- Foot Locker: Slow And Steady Wins The Race
Receive News & Ratings for Synairgen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synairgen and related companies with MarketBeat.com's FREE daily email newsletter.